Persistent URL of this record https://hdl.handle.net/1887/20541
Documents
-
- Download
- Title page_Contents
- open access
-
- Download
- Chapter 1
- open access
- Full text at publishers site
-
- Download
- Chapter 3
- open access
- Full text at publishers site
-
- Download
- Chapter 4
- open access
- Full text at publishers site
-
- Download
- Chapter 5
- open access
- Full text at publishers site
-
- Download
- Chapter 6
- open access
- Full text at publishers site
-
- Download
- Chapter 7
- open access
- Full text at publishers site
-
- Download
- Chapter 8
- open access
- Full text at publishers site
-
- Download
- Chapter 9
- open access
- Full text at publishers site
-
- Download
- Summary and conclusion
- open access
-
- Download
- Summary and conclusions in Dutch
- open access
-
- Download
- List of publications
- open access
-
- Download
- Curriculum Vitae
- open access
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
Sclerostin : a key regulator of bone metabolism
- All authors
- Lierop, A.H.J.M. van
- Supervisor
- Papapoulos, S.E.
- Co-supervisor
- Hamdy, N.A.T.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Leiden University Medical Center (LUMC), Leiden University
- Date
- 2013-02-14
- ISBN (print)
- 9789461916082
Funding
- Sponsorship
- The research descibed in this thesis was carried out within the FP7 program TALOS, financied by the European Union (HEALTH-F2-2008-20199, TALOS). Publication of this thesis was financially supported by: Anna Fonds, J.E. Jurriaanse stichting, Nederlandse Vereniging voor Calcium en Bot, Amgen B.V., Eli Lilly Nederland B.V, Novartis Pharma B.V., Servier Nederland Farma B.V., Goodlife Healthcare B.V. and UCB Pharma B.V.